These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2689221)

  • 1. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
    Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
    FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.
    Brown JE; Echeverria P; Lindberg AA
    Rev Infect Dis; 1991; 13 Suppl 4():S298-303. PubMed ID: 2047653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
    Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
    Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of subunit B of Shiga toxin using a synthetic trisaccharide-based affinity matrix.
    Pozsgay V; Trinh L; Shiloach J; Robbins JB; Donohue-Rolfe A; Calderwood SB
    Bioconjug Chem; 1996; 7(1):45-55. PubMed ID: 8741990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.
    Lindberg AA; Brown JE; Strömberg N; Westling-Ryd M; Schultz JE; Karlsson KA
    J Biol Chem; 1987 Feb; 262(4):1779-85. PubMed ID: 3543013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
    Kongmuang U
    Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
    Miyake M; Utsuno E; Noda M
    Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
    Sandvig K; Olsnes S; Brown JE; Petersen OW; van Deurs B
    J Cell Biol; 1989 Apr; 108(4):1331-43. PubMed ID: 2564398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences.
    Armstrong GD; Fodor E; Vanmaele R
    J Infect Dis; 1991 Dec; 164(6):1160-7. PubMed ID: 1659599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin.
    Kongmuang U; Honda T; Miwatani T
    Infect Immun; 1988 Sep; 56(9):2491-4. PubMed ID: 3045003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.
    O'Brien AD; LaVeck GD
    Infect Immun; 1983 May; 40(2):675-83. PubMed ID: 6341244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
    Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
    Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects.
    Keusch GT; Jacewicz M; Mobassaleh M; Donohue-Rolfe A
    Rev Infect Dis; 1991; 13 Suppl 4():S304-10. PubMed ID: 2047654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.